Creative Planning
TNGX icon

Creative Planning’s Tango Therapeutics TNGX Stock Holding History

Creative Planning’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.11M Buy
52,907
+11,000
+26% +$153K ﹤0.01% 2373
2025
Q4 		$371K Buy
41,907
+6,663
+19% +$57.4K ﹤0.01% 3091
2025
Q3 		$296K Buy
+35,244
New +$239K ﹤0.01% 3157

Other funds holding TNGX

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

Creative Planning's TNGX Position: Q1 2026 in Review

Creative Planning increased its Tango Therapeutics (TNGX) stake by 26% in Q1 2026, buying an estimated $153K and bringing the position to 52,907 shares worth $1.11M. The position accounts for ﹤0.01% of the portfolio, ranked #2373.

Creative Planning first reported a position in TNGX in Q3 2025 and has held it in 3 quarters since. 194 funds tracked by Wall St. Rank hold TNGX as of Q1 2026.

  • Creative Planning held 52,907 shares of Tango Therapeutics worth $1.11M as of Q1 2026.
  • Creative Planning bought 11,000 Tango Therapeutics shares in Q1 2026, an estimated $153K.
  • Tango Therapeutics made up ﹤0.01% of Creative Planning's portfolio in Q1 2026, its #2373 holding.
  • Creative Planning first reported a position in Tango Therapeutics in Q3 2025 and has held it in 3 quarters since.
  • 194 funds tracked by Wall St. Rank held Tango Therapeutics as of Q1 2026.

Based on Creative Planning's 13F filing for Q1 2026, filed 12 May 2026.